Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Vafseo Chronology: Complete Response Letter, Dispute Resolution And A Second-Cycle Approval
Sep 12 2024
•
By
Sue Sutter
Valadustat needed almost 15 years for to move from IND submission to NDA approval. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Review Profiles
More from Product Reviews